ARCHIVES

Tasigna Wins New Indication For CML; Jevtana Approved For Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 23 | June 18, 2010

Download PDF Visit The Full Archive

Related Articles

NIH To Site Visit Animal Facilities

March 18, 1983

FDA Approves Mylotarg For First Relapse Of Acute Myeloid Leukemia In Patients 60+.

June 2, 2000

Von Eschenbach says he will continue as NCI director and give both jobs “100 percent.”

September 30, 2005

Clinical Trials Approved By NCI CTEP During May

June 28, 2002

NIDA Supports Phase III Trial of Anti-Tobacco Vaccine

November 6, 2009

ACS Board Accepts Hammer’s ffer, Will Support Construction Survey

February 17, 1984